List of works by Tindara Franchina

A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives

scientific article

Activity of pegylated liposomal doxorubicin in combination with gemcitabine in triple negative breast cancer with skin involvement: two case reports

scientific article published on 01 May 2012

Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients

scientific article published on 3 June 2015

Author Correction to: Prevalence of Use and Cost of Biological Drugs for Cancer Treatment: A 5-Year Picture from Southern Italy

scientific article published on 30 December 2017

Baseline neutrophilia, derived neutrophil-to-lymphocyte ratio (dNLR), platelet-to-lymphocyte ratio (PLR), and outcome in non small cell lung cancer (NSCLC) treated with Nivolumab or Docetaxel

scientific article published on 19 April 2018

Central nervous system involvement in ALK-rearranged NSCLC: promising strategies to overcome crizotinib resistance

scientific article published on 23 April 2016

Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced non-small cell lung cancer

scientific article

Clinical significance of circulating interleukin-23 as a prognostic factor in breast cancer patients

scientific article published on 01 June 2012

Correction: Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients

scientific article published on 2 July 2015

Correction: The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer

Efficacy of T-DM1 for leptomeningeal and brain metastases in a HER2 positive metastatic breast cancer patient: new directions for systemic therapy - a case report and literature review

scientific article

Efficacy of nab-paclitaxel plus trastuzumab in a long-surviving heavily pretreated HER2-positive breast cancer patient with brain metastases

scientific article

Emerging role of Radium-223 in the growing therapeutic armamentarium of metastatic castration-resistant prostate cancer.

scientific article published on 28 April 2017

Emerging targeted therapies for castration-resistant prostate cancer

scientific article

FGFR a promising druggable target in cancer: Molecular biology and new drugs.

scientific article

Gefitinib in lung cancer therapy: clinical results, predictive markers of response and future perspectives

scientific article published on 20 February 2009

Heterogeneous Responses to Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs) in Patients with Uncommon EGFR Mutations: New Insights and Future Perspectives in this Complex Clinical Scenario ⬇️

article

IL-33/IL-31 axis: a new pathological mechanisms for EGFR tyrosine kinase inhibitors-associated skin toxicity

scientific article published in December 2013

Impact of integrated treatments on patient management in solid tumors: from diagnosis to palliative care

scientific article published on 01 January 2006

Induction chemotherapy with paclitaxel and cisplatin to concurrent radiotherapy and weekly paclitaxel in the treatment of loco-regionally advanced, stage IV (M0), head and neck squamous cell carcinoma. Mature results of a prospective study

scientific article published on 22 November 2011

Influence of EGFR mutational status on metastatic behavior in non squamous non small cell lung cancer

scientific article published on 02 January 2017

Long time response with chemotherapy in ROS1 NSCLC patient with unusual metastatic site

scientific article published on 12 August 2016

Molecular profiling in Italian patients with advanced non-small-cell lung cancer: An observational prospective study.

scientific article published on 16 June 2017

NSCLC and HER2: between lights and shadows

scientific article published on December 2014

Nab-paclitaxel and trastuzumab combination: a promising approach for neoadjuvant treatment in HER2-positive breast cancer

scientific article published on 21 July 2016

Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Outcomes with Nivolumab in Pretreated Non-Small Cell Lung Cancer (NSCLC): A Large Retrospective Multicenter Study

scientific article published on 30 January 2020

Prevalence of Use and Cost of Biological and Non-Biological Targeted Therapies for Cancer Treatment: A 5-Year Picture from Southern Italy

scientific article published on 26 October 2017

Prognostic clinical factors in patients affected by non-small-cell lung cancer receiving Nivolumab

scientific article published on 06 February 2020

Rapid Acquisition of T790M Mutation after Treatment with Afatinib in an NSCLC Patient Harboring EGFR Exon 20 S768I Mutation.

scientific article

The comparison of outcomes from tyrosine kinase inhibitor monotherapy in second- or third-line for advanced non-small-cell lung cancer patients with wild-type or unknown EGFR status

scientific article published on 16 March 2016

The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer

scientific article

The risk of toxicities from trastuzumab, alone or in combination, in an elderly breast cancer population

scientific article published on 10 December 2013

Vaginal Mucosal Melanoma: a Complete Remission after Immunotherapy and '0-7-21' Radiotherapy Regimen (24 Gy/3 fractions/21 days)

scientific article published on 01 September 2020

Paulina is supported by:

About Paulina

Help